The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE
OMB APPROVAL
OMB Number: 3235-0006
Estimated average burden
hours per response: 23.8
COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8
VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP (x$1000) PRN AMT PRN CALL DISCRETION MANAGER SOLE SHARED NONE
ACHAOGEN INC COM 004449104 768 624,544 SH   SOLE   0 0 624,544
CHIASMA INC COM 16706W102 3,722 1,196,776 SH   SOLE   0 0 1,196,776
FATE THERAPEUTICS INC COM 31189P102 26,599 2,073,190 SH   SOLE   0 0 2,073,190
KURA ONCOLOGY INC COM 50127T109 26,063 1,856,307 SH   SOLE   0 0 1,856,307
RUBIUS THERAPEUTICS INC COM 78116T103 42,103 2,618,351 SH   SOLE   0 0 2,618,351